Overview

  • Product name
    Tolazoline hydrochloride
  • Description
    Non-selective, competitive α-adrenoceptor antagonist. Histamine H1 receptor agonist.
  • Biological description
    Non-selective, competitive α-adrenoceptor antagonist. Histamine H1 receptor agonist. Reverses drug-induced vasoconstriction and shows vasodilatory effects in vivo. Orally active.
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Casbeer HC & Knych HK Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses. Vet J 196:504-9 (2013). Read more (PubMed: 23321455) »
  • Yokota S  et al. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets. Am J Vet Res 74:395-402 (2013). Read more (PubMed: 23438114) »
  • Hubbell JA & Muir WW Antagonism of detomidine sedation in the horse using intravenous tolazoline or atipamezole. Equine Vet J 38:238-41 (2006). Read more (PubMed: 16706278) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab145762.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up